Skip to content
AnalystLens

Somnigroup International Annual Report, Year Ended Dec 31, 2025

Filing Date
Filed February 27, 2026
Period End
December 31, 2025
Security
SGI
One revenue dollarkept$0.05
In the record · 2016–202610-K1110-Q328-K220

SGI filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 220 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Mar ’18Mar ’18
  2. Material agreement8-K · May ’20May ’20
  3. Leadership change8-K · Jul ’22Jul ’22
  4. Leadership change8-K · Mar ’25Mar ’25

Summary

Summary of the 10-K filed February 27, 2026. Cited figures are marked; the original filing is the authoritative source.

Somnigroup International Inc. reported net sales of $7,476.5 milliona for 2025, up 51.6% from $4,930.9 million in 2024.

The increase was driven mainly by the February 5, 2025 acquisition of Mattress Firm, which contributed $3,505.4 millionb of sales for the stub period from February 5 through December 31, 2025. Gross margin rose to 42.6% from 41.1%, and operating income increased 19.0% to $754.9 million. Net income was essentially flat at $384.1 million, down 0.1%, while diluted EPS fell 14.8% to $1.84.

Management's adjusted measures were stronger: adjusted operating income rose 41.2% to $1,018.7 millionc, adjusted net income rose 24.2% to $565.3 million, and adjusted EPS rose 5.9% to $2.70. The acquisition substantially increased leverage. Interest expense, net rose 98.7% to $267.9 million, and total debt increased to $4,717.3 million from $3,844.5 million.

The ratio of consolidated indebtedness less netted cash to adjusted EBITDA was 3.21 times, within the 5.00 times maximum in the 2023 Credit Agreement. The company expects to return to its target leverage range of 2.0 to 3.0 times in 2026 and to allocate at least 50% of free cash flow to dividends and share repurchases. Operating cash flow was $800.1 million, and the quarterly dividend was raised to $0.17d per share.

No shares were repurchased in 2025, and approximately $774.5 million remained under the authorization. The company also disclosed that it excluded Mattress Firm from its assessment of internal control over financial reporting for 2025, and that Mattress Firm represented approximately 68% of total consolidated assets and approximately 47% of consolidated net sales. Ernst & Young LLP issued an unqualified opinion on the financial statements and on internal control, with the accounting for the Mattress Firm acquisition identified as a critical audit matter.

Key Highlights

  1. Net sales rose 51.6% to $7,476.5 million, including $3,505.4 million from Mattress Firm for the stub period after the February 5, 2025 acquisition.
  2. Gross margin improved to 42.6% from 41.1%, and adjusted gross margin was 44.4% versus 41.9% in 2024.
  3. GAAP diluted EPS fell 14.8% to $1.84, while adjusted EPS increased 5.9% to $2.70.
  4. Interest expense, net increased 98.7% to $267.9 million, and total debt reached $4,717.3 million at December 31, 2025.
  5. Leverage was 3.21 times against a 5.00 times covenant maximum, and the company expects to return to a 2.0 to 3.0 times target range in 2026.
  6. Operating cash flow was $800.1 million, capital expenditures were $166.9 million, and 2026 capital expenditures are expected to be approximately $250 million.
  7. No shares were repurchased in 2025, and the quarterly dividend increased to $0.17 per share, with approximately $774.5 million remaining under the repurchase program.

Follow one dollar

Of each $1.00 of revenue in FY2025, Somnigroup International kept $0.05.

  1. Revenue$7.48B100.0%
  2. Cost of revenue−$4.29B57.4%
  3. Gross profit$3.18B42.6%
  4. Operating costs−$2.43B32.5%
  5. Operating income$754.9M10.1%
  6. Interest, other & tax−$370.8M5.0%
  7. Net income$384.1M5.1%
Computed from 10-KFY2025filed February 27, 2026Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Where FY2025 revenue went

$7.48B
  • Cost of revenue: $4.29B, 57% of revenue
  • Other operating costs: $2.40B, 32% of revenue
  • Net income: $384.1M, 5.1% of revenue
  • R&D: $32.9M, 0.4% of revenue
  • Interest, other & tax: $370.8M, 5.0% of revenue

Kept 5.1% as net incomeNet income $384.1M · 5.1%R&D $32.9M · 0.4%

Full revenue history →

Financial Statements

FY2025 against FY2024

Line itemFY2025FY2024Change
Revenue$7.48B$4.93B+51.6%
Cost of Revenue$4.29B$2.90B+47.9%
Gross Profit$3.18B$2.03B+57.0%
R&D Expenses$32.90M$30.80M+6.8%
Operating Income$754.90M$634.20M+19.0%
Net Income$384.10M$384.30M−0.1%
EPS (Basic)$1.86$2.21−15.8%
EPS (Diluted)$1.84$2.16−14.8%
Shares Outstanding (Basic)206.00M173.60M+18.7%
Shares Outstanding (Diluted)209.20M178.20M+17.4%

Frequently Asked Questions

  1. How did the Mattress Firm acquisition affect the company's financial results?

    The company completed the acquisition on February 5, 2025 for approximately $5.1 billion net of cash acquired, consisting of $3.1 billion in cash and approximately 34.2 million shares. Mattress Firm contributed $3,505.4 million of net sales and $190.8 million of operating income for the stub period. The acquisition also drove higher depreciation and amortization, interest expense and a working capital deficit of $271.1 million.

  2. Why did net income and EPS decline when sales rose sharply?

    Net income was $384.1 million, down 0.1% from $384.3 million, and diluted EPS fell 14.8% to $1.84 even though operating income rose 19.0%. The filing attributes the gap mainly to higher interest expense, which increased 98.7% to $267.9 million, and to acquisition-related and business combination costs. Adjusted net income rose 24.2% to $565.3 million, and adjusted EPS rose 5.9% to $2.70.

  3. What is the company's current debt and liquidity position?

    Total debt was $4,717.3 million at December 31, 2025, and the leverage ratio was 3.21 times. Cash and cash equivalents were $134.9 million, and $638.7 million was available under the 2023 Credit Agreement, for total liquidity of $773.6 million. The company was in compliance with all financial covenants at year end and expects to return to a 2.0 to 3.0 times leverage target in 2026.

  4. How are shareholder returns being handled after the acquisition?

    The company did not repurchase shares in 2025 and had approximately $774.5 million remaining under its 2016 authorization. Dividends paid totaled $127.4 million in 2025, and the Board declared a $0.17 per share dividend payable March 19, 2026. The company expects to allocate at least 50% of free cash flow to dividends and share repurchases in 2026, subject to debt agreement restrictions.

  5. What are the main risks tied to the Mattress Firm integration and the new product launches?

    The filing cites integration complexity, potential unknown liabilities, and the possibility that expected synergies are not realized. Somnigroup has also committed to a merchandising plan providing 43% of horizontal premium floor slots for third-party premium mattresses, and management determined it was in compliance as of December 31, 2025. The company plans to launch an all-new Stearns & Foster collection in North America in 2026, and new product introductions carry risks of delayed rollout and limited market acceptance.